Experimental Gene Therapy Reduced Seizures But Raised Safety Concerns
This report looked at an experimental gene-targeting treatment in two 2-year-old girls with a very severe form of KCNT1-related epileptic encephalopathy called epilepsy of infancy with migrating focal seizures.